erasin
a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells
Also Known As:
Erlotinib-resistance antagonizing STAT3 inhibitor
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Berg, Angela:
1 article
(12/2017)
|
| 2. | Berg, Thorsten:
1 article
(12/2017)
|
| 3. | Fu, Darwin:
1 article
(12/2017)
|
| 4. | Gilcrest, Tyler:
1 article
(12/2017)
|
| 5. | Krautscheid, Harald:
1 article
(12/2017)
|
| 6. | Lis, Christian:
1 article
(12/2017)
|
| 7. | Meiler, Jens:
1 article
(12/2017)
|
| 8. | Nguyen, Elizabeth:
1 article
(12/2017)
|
| 9. | Roatsch, Martin:
1 article
(12/2017)
|
| 10. | Rubner, Stefan:
1 article
(12/2017)
|
Related Diseases
Related Drugs and Biologics